I think the problem comes in with the "willingness" to be the first to step outside the box. As you noted and alluded to, when you see a rehabs step up and offer baclofen-gabapentin as true-first line recovery options, you will then see true progress in the reformation of alcoholics -and a real change in the industry will soon follow.
I agree that some combination patent (baclofen and another compound) is still conceivable. But that would be different than an "HDB Treatment" patent. It seems pretty clear that there will be no HDB Treatment patent.
But, as you say, that shouldn't prevent the rehab industry or, for that matter, the medical profession from using effective medical treatments. It will be nice when we get the results from a bona fide double blind HDB study. I'm hoping we can all agree on that.
Cassander
Comment